Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma
Clinical trial NCT00438802 · COMPLETED
Trial details
- NCT number
- NCT00438802
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-08-24
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.